These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29508415)

  • 1. Preclinical In Vitro Safety Investigations of Submicron Sized Hemoglobin Based Oxygen Carrier HbMP-700.
    Kao I; Xiong Y; Steffen A; Smuda K; Zhao L; Georgieva R; Pruss A; Bäumler H
    Artif Organs; 2018 May; 42(5):549-559. PubMed ID: 29508415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel hemoglobin particles--promising new-generation hemoglobin-based oxygen carriers.
    Bäumler H; Xiong Y; Liu ZZ; Patzak A; Georgieva R
    Artif Organs; 2014 Aug; 38(8):708-14. PubMed ID: 24962099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonvasoconstrictive hemoglobin particles as oxygen carriers.
    Xiong Y; Liu ZZ; Georgieva R; Smuda K; Steffen A; Sendeski M; Voigt A; Patzak A; Bäumler H
    ACS Nano; 2013 Sep; 7(9):7454-61. PubMed ID: 23915101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin-based red blood cell substitutes and nitric oxide.
    Yu B; Bloch KD; Zapol WM
    Trends Cardiovasc Med; 2009 Apr; 19(3):103-7. PubMed ID: 19679268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of hemoglobin-based oxygen carrier-201 induced vasoconstriction: targeting nitric oxide and endothelin.
    Taverne YJ; de Wijs-Meijler D; Te Lintel Hekkert M; Moon-Massat PF; Dubé GP; Duncker DJ; Merkus D
    J Appl Physiol (1985); 2017 May; 122(5):1227-1237. PubMed ID: 28183818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled nitric oxide prevents systemic and pulmonary vasoconstriction due to hemoglobin-based oxygen carrier infusion: A case report.
    Marrazzo F; Larson G; Sherpa Lama TT; Teggia Droghi M; Joyce M; Ichinose F; Watkins MT; Stowell C; Crowley J; Berra L
    J Crit Care; 2019 Jun; 51():213-216. PubMed ID: 30709560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free oxygen carriers: scientific foundations, clinical development, and new directions.
    Winslow RM
    Biochim Biophys Acta; 2008 Oct; 1784(10):1382-6. PubMed ID: 18555029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin-based blood substitutes: potential free radical toxicity.
    Alayash AI
    Free Radic Biol Med; 1994 Jan; 16(1):137-8. PubMed ID: 8299990
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative In Vivo Effects of Hemoglobin-Based Oxygen Carriers (HBOC) with Varying Prooxidant and Physiological Reactivity.
    Toma VA; Farcaș AD; Roman I; Sevastre B; Hathazi D; Scurtu F; Damian G; Silaghi-Dumitrescu R
    PLoS One; 2016; 11(4):e0153909. PubMed ID: 27097326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Biochemical and Biophysical Characterization of Hemoglobin-Based Oxygen Carrier Therapeutics: All HBOCs Are Not Created Equally.
    Meng F; Kassa T; Jana S; Wood F; Zhang X; Jia Y; D'Agnillo F; Alayash AI
    Bioconjug Chem; 2018 May; 29(5):1560-1575. PubMed ID: 29570272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of recombinant octameric hemoglobin with endothelial cells.
    Gaucher C; Domingues-Hamdi É; Prin-Mathieu C; Menu P; Baudin-Creuza V
    C R Biol; 2015 Feb; 338(2):95-102. PubMed ID: 25543885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design.
    Buehler PW; D'Agnillo F; Schaer DJ
    Trends Mol Med; 2010 Oct; 16(10):447-57. PubMed ID: 20708968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinspired Polydopamine-Coated Hemoglobin as Potential Oxygen Carrier with Antioxidant Properties.
    Wang Q; Zhang R; Lu M; You G; Wang Y; Chen G; Zhao C; Wang Z; Song X; Wu Y; Zhao L; Zhou H
    Biomacromolecules; 2017 Apr; 18(4):1333-1341. PubMed ID: 28323418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential uses of hemoglobin-based oxygen carriers in critical care medicine.
    Creteur J; Vincent JL
    Crit Care Clin; 2009 Apr; 25(2):311-24, Table of Contents. PubMed ID: 19341911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1 on blood pressure, intestinal blood flow, and gut oxygenation in a rat model of hemorrhagic shock.
    Raat NJ; Liu JF; Doyle MP; Burhop KE; Klein J; Ince C
    J Lab Clin Med; 2005 Jan; 145(1):21-32. PubMed ID: 15668658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High- and low-affinity PEGylated hemoglobin-based oxygen carriers: Differential oxidative stress in a Guinea pig transfusion model.
    Alomari E; Ronda L; Bruno S; Paredi G; Marchetti M; Bettati S; Olivari D; Fumagalli F; Novelli D; Ristagno G; Latini R; Cooper CE; Reeder BJ; Mozzarelli A
    Free Radic Biol Med; 2018 Aug; 124():299-310. PubMed ID: 29920341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.
    Alayash AI; D'Agnillo F; Buehler PW
    Expert Opin Biol Ther; 2007 May; 7(5):665-75. PubMed ID: 17477804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstructing hemoglobin-based oxygen carriers.
    Greenburg AG; Light WR; Dubé GP
    Transfusion; 2010 Dec; 50(12):2764-7; author reply 2767. PubMed ID: 21126254
    [No Abstract]   [Full Text] [Related]  

  • 19. How to evaluate blood substitutes for endothelial cell toxicity.
    Gaucher C; Menu P
    Antioxid Redox Signal; 2008 Jul; 10(7):1153-62. PubMed ID: 18331203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood substitutes: why haven't we been more successful?
    Alayash AI
    Trends Biotechnol; 2014 Apr; 32(4):177-85. PubMed ID: 24630491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.